<DOC>
	<DOCNO>NCT00098150</DOCNO>
	<brief_summary>This extension study conduct collect post-treatment safety information patient previously participate core clinical trial .</brief_summary>
	<brief_title>Follow-Up Study Patients Previously Treated With Pimecrolimus Tablets Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<criteria>Consenting patient participate core clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Safety , atopic dermatitis , adverse event , SAE , extension</keyword>
</DOC>